TOKYO -- As Shionogi & Co. races to bring a possible coronavirus vaccine to the market next year, the Japanese drug manufacturer is considering plans to expand production capabilities before clinical trials start.
"While keeping pace with rivals, I expect a release date by around fall 2021 at the latest," Shionogi President and CEO Isao Teshirogi told Nikkei in an interview.
